logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Richard A Haack

This inventor holds 22 USPTO granted patents and 2 published patent applications, primarily in Pharmaceutical Compositions. Top assignees: G.d. Searle & Company, C. D. Searle & Co., Other. Active years: 1988-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard A Haack. Retrieved from https://idiyas.com/inventor/richard-a-haack

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 8

Forward Citations = 241(Granted Patents)


Company Filing History:

goldMedal20 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal1 out of 6 
 
C. D. Searle & Co.
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 1988-2003

Loading Chart...
Areas of Expertise:
LTA4 Hydrolase Inhibitors
Leukotriene B4 Synthesis
Pharmaceutical Compositions
Anti-Inflammatories
Para-Substituted Phenylene
Meta-Substituted Phenylene
Furyl Analogues
Thienyl Analogues
Phenylene Derivatives
Synthesis Inhibitors
Pharmaceutical Methods
Self-Leveling Hockey Puck
22 patents (USPTO):Explore Patents
1. 6506876 - LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use (2003-01-14),
2. 6251944 - Para-substituted phenylene derivatives (2001-06-26),
3. 6146293 - Hockey puck having self-leveling means (2000-11-14),
4. 5952381 - Para-substituted phenylene derivatives (1999-09-14),
5. 5773646 - Meta-substituted phenylene derivatives (1998-06-30),
6. 5723492 - LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use (1998-03-03),
7. 5719306 - LTA.sub.4 hydrolase inhibitors (1998-02-17),
8. 5591756 - LTB4 synthesis inhibitors (1997-01-07),
9. 5585492 - LTA.sub.4 Hydrolase inhibitors (1996-12-17),
10. 5508309 - LTB4 synthesis inhibitors (1996-04-16),
11. 5356919 - Leukotriene B.sub.4 synthesis inhibitors (1994-10-18),
12. 5217981 - LTB4 synthesis inhibitors (1993-06-08),
13. 5179123 - LTB4 synthesis inhibitors (1993-01-12),
14. 5135941 - LTB.sub.4 synthesis inhibitors (1992-08-04),
15. 5112864 - PLA.sub.2 inhibitors as antiinflammatories (1992-05-12),

Title: Richard A Haack: A Pioneer in Invention

Introduction:

Richard A Haack, a visionary inventor based in Chicago, IL (US), is a true pioneer in the realm of innovations. With a passion for pushing the boundaries of what is possible, Haack has dedicated his career to creating groundbreaking inventions that shape the world around us.

Latest Patents:

Haack's latest patents showcase his innovative spirit and dedication to cutting-edge research. One of his recent inventions includes LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use. These compounds are designed to treat inflammatory diseases such as psoriasis, ulcerative colitis, IBD, and asthma. Another notable patent is the para-substituted phenylene derivatives, which represent a class of compounds with diverse applications.

Career Highlights:

Throughout his career, Haack has amassed an impressive portfolio of 22 patents, demonstrating his commitment to innovation and problem-solving. His inventive mind has led to the development of novel solutions with real-world impact.

Collaborations:

Haack has collaborated with esteemed colleagues in his journey towards inventive excellence. Notable coworkers include Stevan Wakefield Djuric and Julie M Miyashiro, who have contributed to the success of his inventions through their expertise and dedication.

Conclusion:

In conclusion, Richard A Haack's relentless pursuit of innovation and dedication to pushing the boundaries of possibility make him a true pioneer in the world of inventions. His inventive spirit, coupled with his collaborative efforts, continues to leave a lasting impact on the field of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…